“On July 23rd, 2025, the Institute for Stem Cell Biology and Regenerative Medicine (ISCBRM) announced the recipients of three prestigious funding programs supporting innovative research in stem cell biology and regenerative medicine.
Eleven Principal Members and mentored fellows were selected to receive awards through the Stinehart-Reed Single Investigator Seed Grant, the Stinehart-Reed Collaborative Seed Grant, and the Siebel Scholar Program.
Together, these programs will provide up to $1.55 million in funding over two years, supporting groundbreaking projects focused on areas such as single-cell and spatial transcriptomics, immune modulation, and stem cell–based therapies for rare diseases.”
Sawan’s goal is to uncover the causes of lymphatic diseases using his 8-day hPSC-derived lympathic cells in vitro, and pave the way for developing targeted, cell-based therapies. Congratulations, Sawan!